Customers Got High After Cannabis Firm Mixed up CBD and THC Say Regulators
Acannabis regulator has issued a product recall after customers reported getting high after taking cannabidiol (CBD), which they did not realize had psychoactive tetrahydrocannabinol (THC) instead.
The Oregon Liquor and Cannabis Commission (OLCC) issued a report on Friday that said it had uncovered why customers had gotten high after using CBD products that were supposedly made from hemp.
According to a report released on Friday and seen by Newsweek, THC ended up in a product not meant to have it while it was at Cura Cannabis's Portland manufacturing site.
Regulators became concerned after a customer in Idaho, who purchased the product in Oregon, complained after they had experienced a strange reaction.
OLCC spokesperson Mark Pettinger told The Oregonian when they did test the sample from the bottle, that it came back "hot."
He added it tested positive for THC and that two more bottles were bought and also found to contain the psychoactive substance.
Following an investigation, state regulators have ordered the recall of the Select Tincture 30ml THC drops - 1,000mg unflavoured.
Although the OLCC preliminary tests found that it did not contain any detectable THC inside other products, they pressed ahead with the recall based on the previous results.
Following the OLCC findings, Curaleaf, which owns Cura Cannabis issued a brief statement, blaming "human error."
In a statement obtained by The Oregonian, Curaleaf said: "After our preliminary investigation, we believe this mistake occurred due to unintentional human error."
The OLCC said the product was produced on May 14, 2021, and estimates that about 630 units were sold beginning June 29 and that 130 units are still on the shelves of retailers.
Customers who have purchased the product are advised to either return it to the OLCC-licensed retailer they bought it from, or destory the product.
If customers have any other complaints about products they have purchased, they should notify the OLCC at firstname.lastname@example.org and include their name and phone number.
Newsweek has contacted the OLCC and Curaleaf for comment.
© 420 Intel